Article Information
History
- May 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Susanna S van Wyk1,
- Marriott Nliwasa2,
- James A Seddon3,4,
- Graeme Hoddinott3,
- Lario Viljoen3,
- Emmanuel Nepolo7,
- Gunar Günther8,9,
- Nunurai Ruswa10,
- Hsien-Ho Lin11,
- Stefan Niemann12,
- Neel Gandhi13,
- Sarita Shah13 and
- Mareli Claassens7,3,*
- 1Centre for Evidence Based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa
- 2Helse Nord Tuberculosis Initiative, Kamuzu University of Health Sciences, Blantyre, Malawi
- 3Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
- 4Department of Infectious Diseases, Imperial College London, London, United Kingdom
- 7Department of Human, Biological and Translational Medical Science, School of Medicine, University of Namibia, Windhoek, Namibia
- 8Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- 9Department of Human, Biological & Translational Medical Science, School of Medicine, University of Namibia, Windhoek, Namibia
- 10Clinical and Programmatic Coordinator for Drug Resistant Tuberculosis, Ministry of Health and Social Services, Windhoek, Namibia
- 11Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taiwan
- 12Molecular and Experimental Mycobacteriology Group and National Reference Center for Mycobacteria, Forschungszentrum Borstel, Germany
- 13Departments of Epidemiology and Global Health, Rollins School of Public Health, Emory University, Atlanta, USA
- ↵*(Corresponding author) Mareli Claassens, mcla{at}sun.ac.za, Mailing address: University of Namibia, Private Bag 13301, Windhoek, Namibia
Posted May 31, 2022.
